OrphanDrug
OrphanDrug
Pharma Knowledge Base

spastic ataxia 5

ORPHA: 313772

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with spastic ataxia 5, sourced from HPO and Orphanet clinical annotations.

PtosisOculomotor apraxiaAtaxiaMild intellectual disabilitySpasticityCerebellar atrophyDysmetriaCerebellar hypoplasiaDystoniaMyoclonusDysphagiaBilateral tonic-clonic seizureDysdiadochokinesisGeneralized myoclonic seizureSpastic paraparesisEEG abnormalityDistal muscle weaknessSpastic dysarthriaPeripheral axonal neuropathyDistal amyotrophyDemyelinating peripheral neuropathySensorimotor neuropathyLower limb muscle weaknessAbnormal mitochondria in muscle tissue

Classification & Codes

Orphanet Code

ORPHA:313772
spastic ataxia 5
OrphanetORPHA:313772
Treatments0 drug(s)
Symptoms on record24 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO